vs
Side-by-side financial comparison of Chefs' Warehouse, Inc. (CHEF) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $1.1B, roughly 1.0× Chefs' Warehouse, Inc.). Chefs' Warehouse, Inc. runs the higher net margin — 1.6% vs -127.8%, a 129.4% gap on every dollar of revenue. On growth, Chefs' Warehouse, Inc. posted the faster year-over-year revenue change (11.4% vs -2.5%). Over the past eight quarters, Chefs' Warehouse, Inc.'s revenue compounded faster (5.3% CAGR vs 1.3%).
Chefs' Warehouse, Inc. is a leading North American specialty food distributor that primarily serves independent restaurants, fine dining venues, hotels, catering firms, and other foodservice operators. It offers a curated portfolio of over 150,000 products including artisanal ingredients, specialty meats, seafood, dairy, pastries, and imported gourmet goods tailored for professional chefs.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
CHEF vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.1B |
| Net Profit | $17.4M | $-1.4B |
| Gross Margin | 24.3% | 32.6% |
| Operating Margin | 3.1% | -116.0% |
| Net Margin | 1.6% | -127.8% |
| Revenue YoY | 11.4% | -2.5% |
| Net Profit YoY | 68.8% | -3093.9% |
| EPS (diluted) | $0.40 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $950.7M | $1.0B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $931.5M | $1.1B | ||
| Q2 24 | $954.7M | $1.1B |
| Q1 26 | $17.4M | — | ||
| Q4 25 | $21.7M | $-1.4B | ||
| Q3 25 | $19.1M | $7.5M | ||
| Q2 25 | $21.2M | $-8.4M | ||
| Q1 25 | $10.3M | $-6.4M | ||
| Q4 24 | $23.9M | $-44.4M | ||
| Q3 24 | $14.1M | $-21.0M | ||
| Q2 24 | $15.5M | $-108.4M |
| Q1 26 | 24.3% | — | ||
| Q4 25 | 24.2% | 32.6% | ||
| Q3 25 | 24.2% | 36.1% | ||
| Q2 25 | 24.6% | 34.4% | ||
| Q1 25 | 23.8% | 37.6% | ||
| Q4 24 | 24.3% | 33.9% | ||
| Q3 24 | 24.1% | 37.2% | ||
| Q2 24 | 24.0% | 37.0% |
| Q1 26 | 3.1% | — | ||
| Q4 25 | 3.8% | -116.0% | ||
| Q3 25 | 3.8% | 7.0% | ||
| Q2 25 | 3.9% | 4.3% | ||
| Q1 25 | 2.4% | 4.5% | ||
| Q4 24 | 4.5% | 10.0% | ||
| Q3 24 | 3.4% | 7.4% | ||
| Q2 24 | 3.5% | -2.5% |
| Q1 26 | 1.6% | — | ||
| Q4 25 | 1.9% | -127.8% | ||
| Q3 25 | 1.9% | 0.7% | ||
| Q2 25 | 2.1% | -0.8% | ||
| Q1 25 | 1.1% | -0.6% | ||
| Q4 24 | 2.3% | -3.9% | ||
| Q3 24 | 1.5% | -1.9% | ||
| Q2 24 | 1.6% | -10.2% |
| Q1 26 | $0.40 | — | ||
| Q4 25 | $0.50 | $-10.23 | ||
| Q3 25 | $0.44 | $0.05 | ||
| Q2 25 | $0.49 | $-0.06 | ||
| Q1 25 | $0.25 | $-0.05 | ||
| Q4 24 | $0.56 | $-0.32 | ||
| Q3 24 | $0.34 | $-0.15 | ||
| Q2 24 | $0.37 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $122.7M | — |
| Total DebtLower is stronger | $750.4M | — |
| Stockholders' EquityBook value | $608.6M | $2.9B |
| Total Assets | $2.0B | $8.5B |
| Debt / EquityLower = less leverage | 1.23× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.7M | — | ||
| Q4 25 | $121.0M | — | ||
| Q3 25 | $65.1M | $432.1M | ||
| Q2 25 | $96.9M | $454.2M | ||
| Q1 25 | $116.5M | $409.9M | ||
| Q4 24 | $114.7M | $558.8M | ||
| Q3 24 | $50.7M | $1.5B | ||
| Q2 24 | $38.3M | $542.8M |
| Q1 26 | $750.4M | — | ||
| Q4 25 | $720.3M | — | ||
| Q3 25 | $711.7M | — | ||
| Q2 25 | $690.2M | — | ||
| Q1 25 | $681.1M | — | ||
| Q4 24 | $688.7M | — | ||
| Q3 24 | $666.6M | — | ||
| Q2 24 | $660.8M | — |
| Q1 26 | $608.6M | — | ||
| Q4 25 | $604.3M | $2.9B | ||
| Q3 25 | $576.6M | $4.4B | ||
| Q2 25 | $557.7M | $4.5B | ||
| Q1 25 | $541.6M | $4.4B | ||
| Q4 24 | $537.6M | $4.3B | ||
| Q3 24 | $480.3M | $4.6B | ||
| Q2 24 | $461.9M | $4.5B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $8.5B | ||
| Q3 25 | $1.9B | $10.1B | ||
| Q2 25 | $1.9B | $10.1B | ||
| Q1 25 | $1.8B | $9.8B | ||
| Q4 24 | $1.9B | $9.6B | ||
| Q3 24 | $1.8B | $11.2B | ||
| Q2 24 | $1.7B | $10.4B |
| Q1 26 | 1.23× | — | ||
| Q4 25 | 1.19× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | 1.26× | — | ||
| Q4 24 | 1.28× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 1.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.3M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | 0.7% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $38.3M | — | ||
| Q4 25 | $73.9M | $175.4M | ||
| Q3 25 | $-8.7M | $51.7M | ||
| Q2 25 | $14.5M | $75.9M | ||
| Q1 25 | $49.6M | $-64.5M | ||
| Q4 24 | $73.0M | $312.6M | ||
| Q3 24 | $19.8M | $42.2M | ||
| Q2 24 | $29.3M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $65.8M | $148.6M | ||
| Q3 25 | $-19.7M | $29.8M | ||
| Q2 25 | $4.5M | $56.7M | ||
| Q1 25 | $37.2M | $-90.0M | ||
| Q4 24 | $64.6M | $274.9M | ||
| Q3 24 | $11.8M | $15.1M | ||
| Q2 24 | $13.3M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 5.8% | 13.4% | ||
| Q3 25 | -1.9% | 2.9% | ||
| Q2 25 | 0.4% | 5.4% | ||
| Q1 25 | 3.9% | -8.6% | ||
| Q4 24 | 6.3% | 24.2% | ||
| Q3 24 | 1.3% | 1.4% | ||
| Q2 24 | 1.4% | -1.8% |
| Q1 26 | 0.7% | — | ||
| Q4 25 | 0.7% | 2.4% | ||
| Q3 25 | 1.1% | 2.1% | ||
| Q2 25 | 1.0% | 1.8% | ||
| Q1 25 | 1.3% | 2.4% | ||
| Q4 24 | 0.8% | 3.3% | ||
| Q3 24 | 0.9% | 2.5% | ||
| Q2 24 | 1.7% | 2.7% |
| Q1 26 | 2.20× | — | ||
| Q4 25 | 3.41× | — | ||
| Q3 25 | -0.46× | 6.89× | ||
| Q2 25 | 0.68× | — | ||
| Q1 25 | 4.82× | — | ||
| Q4 24 | 3.05× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHEF
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
